Jonathan Friedberg, MD: Treating Highly Aggressive Lymphomas

preview_player
Показать описание
Jonathan Friedberg, MD, reviews the recent changes in the WHO classification of highly aggressive lymphomas and how that affects treatment decisions.
  1. American Society of Hematology
  2. lymphoma
  3. hematologic malignancies
Рекомендации по теме
Jonathan Friedberg, MD: 0:06:29

Jonathan Friedberg, MD: Treating Highly Aggressive Lymphomas

ASH Impact Series: 0:03:55

ASH Impact Series: Jonathan Friedberg, MD - How to Treat Highly Aggressive Lymphomas

Debate: Should young 0:15:27

Debate: Should young patients with mantle cell lymphoma be treated aggressively? - No

How will aging 0:00:51

How will aging populations in the West affect treatment of lymphoma?

ASH Meeting on 0:01:24

ASH Meeting on Hematologic Malignancies: Jonathan Friedberg, MD, MMSc

ILyAD study: vitamin 0:02:10

ILyAD study: vitamin D supplementation in low tumor-burden indolent NHL treated with rituximab

Vitamin D in 0:05:38

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituxima...

Elderly patients with 0:02:52

Elderly patients with HL: unmet needs and promising strategies

The limitations of 0:01:19

The limitations of current standards of care for Hodgkin lymphoma

Nivolumab-AVD vs brentuximab 0:02:20

Nivolumab-AVD vs brentuximab vedotin-AVD in pediatric patients with cHL: SWOG S1826 trial

2016 MSK Alumni 0:28:45

2016 MSK Alumni Conference - Jonathan Friedberg, MD

59-Year-Old Man With 0:05:18

59-Year-Old Man With Relapsed Follicular Lymphoma

Oral Therapies for 0:12:14

Oral Therapies for Lymphoma with Jonathan W. Friedberg, MD, MMSc | Everything You Need to Know

Antibody-drug conjugates and 0:00:40

Antibody-drug conjugates and checkpoint inhibitors in Hodgkin lymphoma

Unmet Needs and 0:07:08

Unmet Needs and Therapeutic Targets for Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Emerging therapeutic options 0:02:19

Emerging therapeutic options for Hodgkin lymphoma

Jonathan W. Friedberg, 0:12:05

Jonathan W. Friedberg, M.D., M.M.Sc.,

Jonathan Friedberg, MD, 0:00:46

Jonathan Friedberg, MD, Co-Chair, 2017 ASH Meeting on Hematologic Malignancies

Double Hit Lymphoma 0:23:58

Double Hit Lymphoma - What is it and how should we treat it?

Assessing Optimal Combinations 0:12:53

Assessing Optimal Combinations for Treatment of Lymphoma

2017 ASH MHM: 0:01:55

2017 ASH MHM: Focus on Lymphoma – John Leonard, MD, and Jonathan Friedberg, MD

Strategies to continue 0:02:30

Strategies to continue improving cure rates in HL and where the field is moving

A Decade of 0:01:04

A Decade of Advances: Wilmot Director Dr. Jonathan Friedberg Reflects

Early Relapse Ominous 0:01:47

Early Relapse Ominous in Follicular Lymphoma